MyoKardia Stock Price, News & Analysis

MYOK NASDAQ

Company Description

MyoKardia (NASDAQ: MYOK) is a publicly traded pharmaceuticals: other company in the Health Technology sector.

MYOK stock has gained 316.4% over the past year.

This page provides a comprehensive overview of MYOK stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+316.42%

Performance 1 year

$0.0

Market Cap

53.3M

Shares outstanding

MyoKardia (MYOK) stock. Over the past 12 months, the stock has gained 316.4%.

Latest News

View All

November 15, 2020

+0.05%

MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten

November 13, 2020

+0.03%

MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020

clinical trial

November 11, 2020

-0.06%

MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy

November 5, 2020

0.00%

MyoKardia Reports Third Quarter 2020 Financial Results

earnings

November 4, 2020

+0.48%

MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program

November 2, 2020

-0.11%

MyoKardia Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association’s Annual Scientific Sessions 2020

conferences

MyoKardia has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, earnings, conferences, partnership. View all MYOK news →

SEC Filings

View All

No SEC filings available for MYOK.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MYOK Company Profile & Sector Positioning

MyoKardia (MYOK) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the NASDAQ.